Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study

Introduction Fatigue is the second most common symptom in patients with chronic obstructive pulmonary disease (COPD). Despite its high prevalence, fatigue is often ignored in daily practice. For this reason, little is known about the underlying determinants of fatigue in patients with COPD. The prim...

Full description

Saved in:
Bibliographic Details
Main Authors: Mirjam A G Sprangers, Martijn A Spruit, Emiel F M Wouters, Daisy J A Janssen, Jean W M Muris, Judith B Prins, Yvonne M J Goërtz, Milou Looijmans, Melissa S Y Thong, Jeannette B Peters, Chris Burtin, Yvonne Meertens-Kerris, Arnold Coors, Jan H Vercoulen
Format: Article
Language:English
Published: BMJ Publishing Group 2018-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/8/4/e021745.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832574287953788928
author Mirjam A G Sprangers
Martijn A Spruit
Emiel F M Wouters
Daisy J A Janssen
Jean W M Muris
Judith B Prins
Yvonne M J Goërtz
Milou Looijmans
Melissa S Y Thong
Jeannette B Peters
Chris Burtin
Yvonne Meertens-Kerris
Arnold Coors
Jan H Vercoulen
author_facet Mirjam A G Sprangers
Martijn A Spruit
Emiel F M Wouters
Daisy J A Janssen
Jean W M Muris
Judith B Prins
Yvonne M J Goërtz
Milou Looijmans
Melissa S Y Thong
Jeannette B Peters
Chris Burtin
Yvonne Meertens-Kerris
Arnold Coors
Jan H Vercoulen
author_sort Mirjam A G Sprangers
collection DOAJ
description Introduction Fatigue is the second most common symptom in patients with chronic obstructive pulmonary disease (COPD). Despite its high prevalence, fatigue is often ignored in daily practice. For this reason, little is known about the underlying determinants of fatigue in patients with COPD. The primary objectives of this study are to chart the course of fatigue in patients with COPD, to identify the physical, systemic, psychological and behavioural factors that precipitate and perpetuate fatigue in patients with COPD, to evaluate the impact of exacerbation-related hospitalisations on fatigue and to better understand the association between fatigue and 2-year all-cause hospitalisation and mortality in patients with COPD. The secondary aim is to identify diurnal differences in fatigue by using ecological momentary assessment (EMA). This manuscript describes the protocol of the FAntasTIGUE study and gives an overview of the possible strengths, weaknesses and clinical implications.Methods and analysis A 2-year longitudinal, observational study, enrolling 400 patients with clinically stable COPD has been designed. Fatigue, the primary outcome, will be measured by the subjective fatigue subscale of the Checklist Individual Strength (CIS-Fatigue). The secondary outcome is the day-to-day/diurnal fatigue, registered in a subsample (n=60) by EMA. CIS-Fatigue and EMA will be evaluated at baseline, and at 4, 8 and 12 months. The precipitating and perpetuating factors of fatigue (physical, psychological, behavioural and systemic) will be assessed at baseline and at 12 months. Additional assessments will be conducted following hospitalisation due to an exacerbation of COPD that occurs between baseline and 12 months. Finally, at 18 and 24 months the participants will be followed up on their fatigue, number of exacerbations, exacerbation-related hospitalisation and survival.Ethics and dissemination This protocol was approved by the Medical research Ethics Committees United, Nieuwegein, the Netherlands (NL60484.100.17).Trial registration number NTR6933; Pre-results.
format Article
id doaj-art-470177c702504c24a3de4604d3b3f49f
institution Kabale University
issn 2044-6055
language English
publishDate 2018-04-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-470177c702504c24a3de4604d3b3f49f2025-02-01T19:15:10ZengBMJ Publishing GroupBMJ Open2044-60552018-04-018410.1136/bmjopen-2018-021745Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE studyMirjam A G Sprangers0Martijn A Spruit1Emiel F M Wouters2Daisy J A Janssen3Jean W M Muris4Judith B Prins5Yvonne M J Goërtz6Milou Looijmans7Melissa S Y Thong8Jeannette B Peters9Chris Burtin10Yvonne Meertens-Kerris11Arnold Coors12Jan H Vercoulen134 Department of Medical Psychology, Academic Medical Centre University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The NetherlandsDepartment of Research and Development, Ciro, Horn, the Netherlands6 Ludwig Boltzmann Institute for Lung Health, Vienna, AustriaDepartment of Health Services Research, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the NetherlandsFamily Medicine, Maastricht University, Research Institute CAPHRI, Maastricht, Limburg, The NetherlandsMedical Psychology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands1 Department of Research and Education, Ciro, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands2 Department of Medical Psychology and Department of Pulmonary Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands4 Department of Medical Psychology, Academic Medical Centre University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands2 Department of Medical Psychology and Department of Pulmonary Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsREVAL—Rehabilitation Research Center, Faculty of Rehabilitation Sciences, BIOMED Biomedical Research Institute, Hasselt University, Hasselt, Belgium6 Patient Advisory Board, Ciro, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands7 Patient Advisory Board, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands2 Department of Medical Psychology and Department of Pulmonary Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsIntroduction Fatigue is the second most common symptom in patients with chronic obstructive pulmonary disease (COPD). Despite its high prevalence, fatigue is often ignored in daily practice. For this reason, little is known about the underlying determinants of fatigue in patients with COPD. The primary objectives of this study are to chart the course of fatigue in patients with COPD, to identify the physical, systemic, psychological and behavioural factors that precipitate and perpetuate fatigue in patients with COPD, to evaluate the impact of exacerbation-related hospitalisations on fatigue and to better understand the association between fatigue and 2-year all-cause hospitalisation and mortality in patients with COPD. The secondary aim is to identify diurnal differences in fatigue by using ecological momentary assessment (EMA). This manuscript describes the protocol of the FAntasTIGUE study and gives an overview of the possible strengths, weaknesses and clinical implications.Methods and analysis A 2-year longitudinal, observational study, enrolling 400 patients with clinically stable COPD has been designed. Fatigue, the primary outcome, will be measured by the subjective fatigue subscale of the Checklist Individual Strength (CIS-Fatigue). The secondary outcome is the day-to-day/diurnal fatigue, registered in a subsample (n=60) by EMA. CIS-Fatigue and EMA will be evaluated at baseline, and at 4, 8 and 12 months. The precipitating and perpetuating factors of fatigue (physical, psychological, behavioural and systemic) will be assessed at baseline and at 12 months. Additional assessments will be conducted following hospitalisation due to an exacerbation of COPD that occurs between baseline and 12 months. Finally, at 18 and 24 months the participants will be followed up on their fatigue, number of exacerbations, exacerbation-related hospitalisation and survival.Ethics and dissemination This protocol was approved by the Medical research Ethics Committees United, Nieuwegein, the Netherlands (NL60484.100.17).Trial registration number NTR6933; Pre-results.https://bmjopen.bmj.com/content/8/4/e021745.full
spellingShingle Mirjam A G Sprangers
Martijn A Spruit
Emiel F M Wouters
Daisy J A Janssen
Jean W M Muris
Judith B Prins
Yvonne M J Goërtz
Milou Looijmans
Melissa S Y Thong
Jeannette B Peters
Chris Burtin
Yvonne Meertens-Kerris
Arnold Coors
Jan H Vercoulen
Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study
BMJ Open
title Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study
title_full Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study
title_fullStr Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study
title_full_unstemmed Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study
title_short Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study
title_sort fatigue in patients with chronic obstructive pulmonary disease protocol of the dutch multicentre longitudinal observational fantastigue study
url https://bmjopen.bmj.com/content/8/4/e021745.full
work_keys_str_mv AT mirjamagsprangers fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT martijnaspruit fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT emielfmwouters fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT daisyjajanssen fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT jeanwmmuris fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT judithbprins fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT yvonnemjgoertz fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT miloulooijmans fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT melissasythong fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT jeannettebpeters fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT chrisburtin fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT yvonnemeertenskerris fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT arnoldcoors fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy
AT janhvercoulen fatigueinpatientswithchronicobstructivepulmonarydiseaseprotocolofthedutchmulticentrelongitudinalobservationalfantastiguestudy